Status:
COMPLETED
Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families
Lead Sponsor:
VA Office of Research and Development
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evidence-based psychotherapies (EBP) for PTSD, such as Prolonged Exposure (PE), result in clinically significant symptom relief for many. Yet, adherence to this treatment (i.e., session attendance and...
Detailed Description
Impacts. This study aims to improve Veterans' adherence to evidence-based treatment for PTSD, through increasing family support for treatment. Improving retention rates in evidence-based PTSD treatmen...
Eligibility Criteria
Inclusion
- Male or female veterans at least 18 years old. Recruitment is limited to Veterans enrolled in VHA care.
- Participant meets DSM-5 diagnostic criteria for PTSD or subthreshold PTSD. Consistent with recommendations, subthreshold PTSD will be defined as endorsement of criteria A (trauma), F (duration), and G (impairment), with at least one symptom from each of the remaining diagnostic criteria (Brancu et al., 2016).
- Has an intimate partner, family member, or friend with whom they have contact with at least 3 times a week
- Willing to allow this person to participate in the study.
- Provides informed consent.
- Speaks and reads English.
Exclusion
- Current suicidal or homicidal ideation with intent and/or plan.
- Meets DSM-5 criteria for a manic of psychotic episode in the past 3 months.
- Meets DSM-5 diagnostic criteria for a severe substance use disorder in the past 3 months. Of note, subjects can be abusing or dependent upon nicotine or marijuana and still be included in the study.
- Moderate relationship violence between the identified support person and the Veteran, defined as one or more episodes of severe violence in the past year (e.g., punched, kicked, or beat up).
- Support person screens positive for PTSD on a self-report instrument (PCL).
- Having an ongoing medical condition that would interfere with ability to attend weekly treatment sessions.
- Having any planned upcoming major medical procedures over the next several months that would interfere with ability to attend weekly treatment sessions.
- Veteran and/or SP fails to complete baseline survey
- Episode of mania/psychosis in past 3 months
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT03256227
Start Date
January 15 2018
End Date
June 30 2022
Last Update
June 14 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, United States, 30033
2
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, United States, 48105
3
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, United States, 55417